FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Wilson Tang

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Physiology

Disease Progression

Procedures

Cardiac Resynchronization Therapy

Co-author Network

Publications

TOP 3
Jeffrey M Testani; Anjali Tiku-Owens; Meredith A Brisco; Paul R Forfia; Stephen E Kimmel; W H Wilson Tang; Steven G Coca
Potential effects of digoxin on long-term renal and clinical outcomes in chronic heart failure.
Robert A Koeth; Ronald M Krauss; Bruce Levison; James D Lewis; Hongzhe Li; Lin Li; Aldons J Lusis; Elin Org; Brendan T Sheehy; Jonathan D Smith; W H Wilson Tang; Zeneng Wang; Manya Warrier; Gary D Wu; Yuping Wu; Earl B Britt; J Mark Brown; Jennifer A Buffa; Frederic D Bushman; Jun Chen; Joseph A DiDonato; Xiaoming Fu; Stanley L Hazen
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis.
W H Wilson Tang; Yuping Wu; Earl B Britt; Naveed Iqbal; Stanley L Hazen
Detectable subclinical myocardial necrosis is associated with cardiovascular risk in stable patients with diabetes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Wilson Tang (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jeffrey M Testani; Anjali Tiku-Owens; Meredith A Brisco; Paul R Forfia; Stephen E Kimmel; W H Wilson Tang; Steven G Coca
Potential effects of digoxin on long-term renal and clinical outcomes in chronic heart failure.
Journal of cardiac failure 2013;19(5):295-302.
2013: Robert A Koeth; Ronald M Krauss; Bruce Levison; James D Lewis; Hongzhe Li; Lin Li; Aldons J Lusis; Elin Org; Brendan T Sheehy; Jonathan D Smith; W H Wilson Tang; Zeneng Wang; Manya Warrier; Gary D Wu; Yuping Wu; Earl B Britt; J Mark Brown; Jennifer A Buffa; Frederic D Bushman; Jun Chen; Joseph A DiDonato; Xiaoming Fu; Stanley L Hazen
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis.
Nature medicine 2013;19(5):576-85.
2013: W H Wilson Tang; Yuping Wu; Earl B Britt; Naveed Iqbal; Stanley L Hazen
Detectable subclinical myocardial necrosis is associated with cardiovascular risk in stable patients with diabetes.
Diabetes care 2013;36(5):1126-31.
2013: Paaladinesh Thavendiranathan; Arun Dahiya; Milind Y Desai; Dermot Phelan; W H Wilson Tang
Isolated left ventricular non-compaction controversies in diagnostic criteria, adverse outcomes and management.
Heart (British Cardiac Society) 2013;99(10):681-9.
2013: Gang Zhou; W H Wilson Tang; Hooman Allayee; Jaana Hartiala; Stanley L Hazen; Gopal K Marathe; Thomas M McIntyre
Aspirin Hydrolysis in Plasma Is a Variable Function of Butyrylcholinesterase and Platelet-activating Factor Acetylhydrolase 1b2 (PAFAH1b2).
The Journal of biological chemistry 2013;288(17):11940-8.
2013: W H Wilson Tang; Zeneng Wang; Yuping Wu; Earl B Britt; Xiaoming Fu; Robert A Koeth; Bruce S Levison; Stanley L Hazen
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
The New England journal of medicine 2013;368(17):1575-84.
2013: W H Wilson Tang; David O Taylor; Edgard Wehbe; Sevag Demirjian; Mazen Hanna; Maria Patarroyo; Randall C Starling
Reply.
Journal of the American College of Cardiology 2013;61(15):1659.
2013: Michael A Samara; W H Wilson Tang; Lily Tranchito; Jamie Viterna; Yuping Wu; Frank Cikach; Zeynep Gul; Daniel Laskowski; Kelly M Paschke; Raed A Dweik
Single exhaled breath metabolomic analysis identifies unique breathprint in patients with acute decompensated heart failure.
Journal of the American College of Cardiology 2013;61(13):1463-4.
2013: W H Wilson Tang; Richard W Troughton; Zeneng Wang; Allen Borowski; Allan L Klein; Kevin Shrestha; Stanley L Hazen
Protein carbamylation in chronic systolic heart failure: relationship with renal impairment and adverse long-term outcomes.
Journal of cardiac failure 2013;19(4):219-24.
2013: David J Kennedy; Shirley Mann; Michael Pepoy; W H Wilson Tang; Yuping Wu; Yiying Fan; Stanley L Hazen
Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney disease.
Journal of the American Heart Association 2013;2(2):e000104.
2013: Robert A Koeth; W H Wilson Tang; Zeneng Wang; Xiaoming Fu; Kamyar Kalantar-Zadeh; Stanley L Hazen
Protein carbamylation predicts mortality in ESRD.
Journal of the American Society of Nephrology : JASN 2013;24(5):853-61.
2013: Matthias Dupont; Michael Finucan; Wilfried Mullens; Randall C Starling; David O Taylor; W H Wilson Tang
Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment.
European journal of heart failure 2013;15(4):433-40.
2013: Nael Hawwa; Martin J Schreiber; W H Wilson Tang
Pharmacologic management of chronic reno-cardiac syndrome.
Current heart failure reports 2013;10(1):54-62.
2013: Frederik Hendrik Verbrugge; Jan Vercammen; David Verhaert; Matthias Dupont; Linda Jacobs; W H Wilson Tang; Pieter Vandervoort; Wilfried Mullens
Time from emerging heart failure symptoms to cardiac resynchronisation therapy: impact on clinical response.
Heart (British Cardiac Society) 2013;99(5):314-9.
2013: Gille Koppers; Robert Dion; Herbert Gutermann; Rozette Reyskens; W H Wilson Tang; Chris Van Kerrebroeck; Pieter Vandervoort; Frederik H Verbrugge; David Verhaert; Wilfried Mullens
Clinical outcomes after tricuspid valve annuloplasty in addition to mitral valve surgery.
Congestive heart failure (Greenwich, Conn.) 2013;19(2):70-6.
2013: W H Wilson Tang; Yuping Wu; Naveed Iqbal; Stanley L Hazen
Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic status.
The American journal of cardiology 2013;111(4):465-70.
2013: Erika L Lundgrin; Donald R Neumann; Margaret M Park; Jacqueline Sharp; W H Wilson Tang; James D Thomas; Rubin M Tuder; Kewal Asosingh; Suzy A A Comhair; Laura Davis; Frank P DiFilippo; Iva Dostanic; Brian B Graham; Serpil C Erzurum
Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year.
Annals of the American Thoracic Society 2013;10(1):1-9.
2013: W H Wilson Tang; Richard W Troughton; Zeneng Wang; Allan L Klein; Kevin Shrestha; Stanley L Hazen
Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure.
Journal of cardiac failure 2013;19(2):87-93.
2013: Frederik H Verbrugge; Jan Vercammen; David Verhaert; Philippe De Vusser; Matthias Dupont; Linda Jacobs; Maximo Rivero-Ayerza; W H Wilson Tang; Hugo Van Herendael; Pieter Vandervoort; Wilfried Mullens
Response to cardiac resynchronization therapy in elderly patients (≥70 years) and octogenarians.
European journal of heart failure 2013;15(2):203-10.
2013: Nancy M Albert; Jennifer Forney; Benjamin Nutter; Ellen Slifcak; W H Wilson Tang
A randomized controlled pilot study of outcomes of strict allowance of fluid therapy in hyponatremic heart failure (SALT-HF).
Journal of cardiac failure 2013;19(1):1-9.
2013: David J Kennedy; Jiang Liu; Joseph I Shapiro; W H Wilson Tang; Jian Tian; Jamie Viterna; Kristen Westfall; Zijian Xie; David J Bartlett; Yiliang Chen; Wenxin Huang; Roy L Silverstein
CD36 and Na/K-ATPase-α1 form a proinflammatory signaling loop in kidney.
Hypertension 2013;61(1):216-24.
2013: John Rickard; David Spragg; W H Wilson Tang; Daniel Cantillon; Alan Cheng; Mina K Chung; Bruce L Wilkoff; Niraj Varma
QRS narrowing is associated with reverse remodeling in patients with chronic right ventricular pacing upgraded to cardiac resynchronization therapy.
Heart rhythm : the official journal of the Heart Rhythm Society 2013;10(1):55-60.
2012: W H Wilson Tang
Reconsidering ultrafiltration in the acute cardiorenal syndrome.
The New England journal of medicine 2012;367(24):2351-2.
2012: W H Wilson Tang
Targeting endogenous antioxidants to prevent cardiovascular diseases.
Journal of the American Heart Association 2012;1(6):e005215.
2012: Vijaiganesh Nagarajan; Adrian V Hernandez; W H Wilson Tang
Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review.
Heart (British Cardiac Society) 2012;98(24):1778-86.
2012: Hirohiko Motoki; Kevin Shrestha; W H Wilson Tang; James D Thomas; Richard W Troughton; Allen Borowski; Allan L Klein
Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure.
Journal of the American College of Cardiology 2012;60(20):2074-81.
2012: Leonor Thomson; Epida Tsika; Yuping Wu; Paschalis-Thomas Doulias; Todd M Greco; Stanley L Hazen; Richard Lightfoot; Marissa Martinez; Ioannis Parastatidis; W H Wilson Tang; Margarita Tenopoulou; Harry Ischiropoulos
Immunoglobulins against tyrosine-nitrated epitopes in coronary artery disease.
Circulation 2012;126(20):2392-401.
2012: Maria Patarroyo; Randall C Starling; Sevag Demirjian; Mazen Hanna; David O Taylor; Edgard Wehbe; W H Wilson Tang
Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure.
Journal of the American College of Cardiology 2012;60(19):1906-12.
2012: Frederik H Verbrugge; Jan Vercammen; David Verhaert; Philippe de Vusser; Matthias Dupont; Linda Jacobs; Maximo Rivero-Ayerza; W H Wilson Tang; Hugo Van Herendael; Pieter Vandervoort; Wilfried Mullens
Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodeling.
Journal of cardiac failure 2012;18(11):845-53.
2012: Matthias Dupont; Wilfried Mullens; Hadi N Skouri; Randall C Starling; David O Taylor; Yuping Wu; Zuheir Abrahams; W H Wilson Tang
Prognostic role of pulmonary arterial capacitance in advanced heart failure.
Circulation. Heart failure 2012;5(6):778-85.
2012: W H Wilson Tang; Yuping Wu; Hooman Allayee; Jeanette Erdmann; Yiying Fan; Jaana Hartiala; Sekar Kathiresan; Ruth McPherson; Robert Roberts; Alexandre Stewart; Stanley L Hazen
Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(11):2803-12.
2012: Kevin Shrestha; Dhssraj Singh; Matthias Dupont; Zhili Shao; W H Wilson Tang
Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure.
The American journal of cardiology 2012;110(9):1329-35.
2012: G Michael Felker; Gregg C Fonarow; Vic Hasselblad; Gretchen M Heizer; Adrian F Hernandez; Barry M Massie; John J V McMurray; Marco Metra; Stefan D Anker; Paul W Armstrong; Dan Atar; Javed Butler; Robert M Califf; Kenneth Dickstein; Randall C Starling; W H Wilson Tang; Richard W Troughton; Adriaan A Voors; Christopher M O'Connor
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study.
European journal of heart failure 2012;14(11):1257-64.
2012: Shantanu Sarkar; W H Wilson Tang; Eduardo N Warman; William T Abraham; George H Crossley; Jodi Koehler; David J Whellan
Burden of atrial fibrillation and poor rate control detected by continuous monitoring and the risk for heart failure hospitalization.
American heart journal 2012;164(4):616-24.
2012: Andres Schuster; Akanksha Thakur; James D Thomas; Zeneng Wang; Allen Borowski; W H Wilson Tang
Increased exhaled nitric oxide levels after exercise in patients with chronic systolic heart failure with pulmonary venous hypertension.
Journal of cardiac failure 2012;18(10):799-803.
2012: John Rickard; David Spragg; W H Wilson Tang; Bryan Baranowski; Edmond M Cronin; Gregory Jackson; Bruce L Wilkoff; Niraj Varma
QRS prolongation induced by cardiac resynchronization therapy correlates with deterioration in left ventricular function.
Heart rhythm : the official journal of the Heart Rhythm Society 2012;9(10):1674-8.
2012: Kevin Shrestha; Allen G Borowski; Allan L Klein; Richard W Troughton; W H Wilson Tang
Association between systemic neutrophil gelatinase-associated lipocalin and anemia, relative hypochromia, and inflammation in chronic systolic heart failure.
Congestive heart failure (Greenwich, Conn.) 2012;18(5):239-44.
2012: Vijaiganesh Nagarajan; W H Wilson Tang
Management of comorbid conditions in heart failure: a review.
The Medical clinics of North America 2012;96(5):975-85.
2012: Vijaiganesh Nagarajan; Mohammed Chamsi-Pasha; W H Wilson Tang
The role of aldosterone receptor antagonists in the management of heart failure: an update.
Cleveland Clinic journal of medicine 2012;79(9):631-9.
2012: Matthias Dupont; Stanley L Hazen; Yuping Wu; W H Wilson Tang
Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events.
Circulation. Heart failure 2012;5(5):602-9.
2012: Hirad Yarmohammadi; Tristan Klosterman; Bruce D Lindsay; W H Wilson Tang; M Chadi Alraies; Mandeep Bhargava; Gaganpreet Grewal; Allan L Klein
Transesophageal echocardiography and cardioversion trends in patients with atrial fibrillation: a 10-year survey.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2012;25(9):962-8.
2012: Matthias Dupont; Michael Finucan; Alaa Gabi; Wilfried Mullens; John Rickard; Bryan Baranowski; Thomas Dresing; Niraj Varma; Bruce L Wilkoff; W H Wilson Tang
Differential response to cardiac resynchronization therapy and clinical outcomes according to QRS morphology and QRS duration.
Journal of the American College of Cardiology 2012;60(7):592-8.
2012: Slava Epelman; W H Wilson Tang
H(2)S--the newest gaseous messenger on the block.
Journal of cardiac failure 2012;18(8):597-9.
2012: Rajan S Patel; Hooman Allayee; Jaana Hartiala; Stanley L Hazen; Ying X Liu; Ronak Patel; S Tanveer Rab; Ayaz Rahman; Habib Samady; Salman Sher; Shaoyong Su; Yan V Sun; W H Wilson Tang; Viola Vaccarino; Emir Veledar; A Maziar Zafari; Arshed A Quyyumi
Association of a genetic risk score with prevalent and incident myocardial infarction in subjects undergoing coronary angiography.
Circulation. Cardiovascular genetics 2012;5(4):441-9.
2012: W H Wilson Tang; John Boehmer; Daniel Gras
Multispecialty approach: the need for heart failure disease management for refining cardiac resynchronization therapy.
Heart rhythm : the official journal of the Heart Rhythm Society 2012;9(8 Suppl):S45-50.
2012: Marissa Martinez; Angela Mills; W H Wilson Tang; Richard Lightfoot; Adam Cuker; Yiying Fan; Stanley L Hazen; Harry Ischiropoulos
Nitrated fibrinogen is a biomarker of oxidative stress in venous thromboembolism.
Free radical biology & medicine 2012;53(2):230-6.
2012: Todd Senn; Stanley L Hazen; W H Wilson Tang
Translating metabolomics to cardiovascular biomarkers.
Progress in cardiovascular diseases 2012;55(1):70-6.
2012: W H Wilson Tang
Biomarkers in cardiovascular diseases: how can the "-omics" revolution be applicable at the bedside. Introduction.
Progress in cardiovascular diseases 2012;55(1):1-2.
2012: Zubin J Eapen; G Michael Felker; Adrian F Hernandez; A Michael Lincoff; Kenneth W Mahaffey; W H Wilson Tang; Matthew T Roe
Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward.
Circulation. Cardiovascular quality and outcomes 2012;5(4):594-600.
2012: Gaganpreet K Grewal; Tristan B Klosterman; Bruce D Lindsay; Kevin Shrestha; W H Wilson Tang; Brandon C Varr; Hirad Yarmohammadi; Andrew O Zurick; Allan L Klein
Indications for TEE before cardioversion for atrial fibrillation: implications for appropriateness criteria.
JACC. Cardiovascular imaging 2012;5(6):641-8.
2012: Matthias Dupont; Cynthia Kovach; Anjli P Maroo; Mario Scarcipino; Kevin Shrestha; Dhssraj Singh; Adiveh Awad; W H Wilson Tang
Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure.
European journal of heart failure 2012;14(6):597-604.
2012: Samar Farha; Carol Farver; Fred Hsieh; James E Loyd; Margaret Park; Jacqueline Sharp; W H Wilson Tang; Jim Thomas; Kewal Asosingh; Suzy A A Comhair; Serpil C Erzurum
Mast cell number, phenotype, and function in human pulmonary arterial hypertension.
Pulmonary circulation 2012;2(2):220-8.
2012: Inder S Anand; Niranjan Chakravarthy; Barry H Greenberg; Rodolphe P Katra; Imad Libbus; W H Wilson Tang
Design and performance of a multisensor heart failure monitoring algorithm: results from the multisensor monitoring in congestive heart failure (MUSIC) study.
Journal of cardiac failure 2012;18(4):289-95.
2012: Javed Butler; Peter E Carson; Sean P Collins; Monica Colvin-Adams; Justin A Ezekowitz; James C Fang; Michael M Givertz; Adrian F Hernandez; Ray E Hershberger; Stuart D Katz; Joseph G Rogers; John A Spertus; William G Stevenson; Wendy Gattis Stough; NK Sweitzer; W H Wilson Tang; John R Teerlink; Mary N Walsh; Cheryl A Westlake Canary; Nancy M Albert; Randall C Starling
Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee.
Journal of cardiac failure 2012;18(4):265-81.
2012: Robert W Davies; Stephen G Ellis; James C Engert; Stephen E Epstein; Jeanette Erdmann; Jane Francisca Ferguson; Christopher B Granger; Alistair S Hall; Stanley L Hazen; Christian Hengstenberg; Inke R König; William E Kraus; Christina Loley; Janja Nahrstaedt; Daniel J Rader; Muredach P Reilly; Robert Roberts; Nilesh J Samani; Stefan Schreiber; Heribert Schunkert; Svati H Shah; Alexandre Stewart; W H Wilson Tang; George A Wells; H-Erich Wichmann; Sonia S Anand; Mary S Burnett; Li Chen; Sonny Dandona; Ruth McPherson
A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex.
Circulation. Cardiovascular genetics 2012;5(2):217-25.
2012: Zhili Shao; Kevin Shrestha; Wendy Sweet; Allen Borowski; Stanley L Hazen; Christine S Moravec; Akanksha Thakur; James D Thomas; Zeneng Wang; W H Wilson Tang
Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1.
Journal of the American College of Cardiology 2012;59(13):1150-8.
2012: Zain Ahmed; W H Wilson Tang
Pharmacologic strategies to target oxidative stress in heart failure.
Current heart failure reports 2012;9(1):14-22.
2012: Maria Patarroyo; Kevin Shrestha; Cesar Simbaqueba; Nicholas Smedira; Randall C Starling; W H Wilson Tang; David O Taylor
Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2012;31(3):282-7.
2012: Richard M Steingart; George L Bakris; Helen X Chen; Ming-Hui Chen; Thomas Force; S Percy Ivy; Carl V Leier; Daniel Lenihan; JoAnn Lindenfeld; Glenn Liu; Michael L Maitland; Scot C Remick; W H Wilson Tang
Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors.
American heart journal 2012;163(2):156-63.
2012: Clay A Cauthen; Anil Jain; Wilson Tong; W H Wilson Tang
Progressive rise in red cell distribution width is associated with disease progression in ambulatory patients with chronic heart failure.
Journal of cardiac failure 2012;18(2):146-52.
2012: William G Stevenson; Wendy Gattis Stough; NK Sweitzer; W H Wilson Tang; John R Teerlink; Mary N Walsh; Cheryl A Westlake Canary; Nancy M Albert; Javed Butler; Peter E Carson; Sean P Collins; Monica Colvin-Adams; Justin A Ezekowitz; James C Fang; Michael M Givertz; Adrian F Hernandez; Ray E Hershberger; Stuart D Katz; Joseph G Rogers; John A Spertus; Randall C Starling
Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee.
Journal of cardiac failure 2012;18(2):94-106.
2012: W H Wilson Tang; Yuping Wu; Ruth McPherson; Robert Roberts; Alexandre Stewart; Hooman Allayee; Yiying Fan; Paul L Fox; Jaana Hartiala; Stanley L Hazen
Clinical and genetic association of serum ceruloplasmin with cardiovascular risk.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(2):516-22.
2012: Anna P Pilbrow; A Mark Richards; Wendy E Sweet; W H Wilson Tang; Richard W Troughton; Nancy M Wang; Per Eriksson; Lasse Folkersen; Anders Franco-Cereceda; Anders Gabrielsen; LA McNoe; Christine S Moravec; John F Pearson; Michael A Black; Chris M Brown; Vicky A Cameron
The chromosome 9p21.3 coronary heart disease risk allele is associated with altered gene expression in normal heart and vascular tissues.
PloS one 2012;7(6):e39574.
2012: Mazen A Hanna; Sey M Lau; James O O'Neill; Emil P Paganini; Randall C Starling; W H Wilson Tang; Boon W Teo; Frederick Van Lente; David M Weinstein; David O Taylor
Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure.
Congestive heart failure (Greenwich, Conn.) 2012;18(1):54-63.
2012: Arvind Bhimaraj; W H Wilson Tang
Role of oxidative stress in disease progression in Stage B, a pre-cursor of heart failure.
Heart failure clinics 2012;8(1):101-11.
2012: David Verhaert; Bruce L Wilkoff; Kathy Wolski; Zoran B Popović; Chirapa Puntawangkoon; Randall C Starling; W H Wilson Tang; James D Thomas; Sabe De; Brian P Griffin; Richard A Grimm
Impact of mitral regurgitation on reverse remodeling and outcome in patients undergoing cardiac resynchronization therapy.
Circulation. Cardiovascular imaging 2012;5(1):21-6.
2011: Stephen J Nicholls; Steven E Nissen; W H Wilson Tang; Danielle Brennan; Marie-Luise Brennan; Shirley Mann; Stanley L Hazen
Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain.
Clinical chemistry 2011;57(12):1762-70.
2011: John Rickard; W H Wilson Tang; Patrick J Tchou; Niraj Varma; Mohamed Bassiouny; Edmond M Cronin; David O Martin; Mark J Niebauer; Bruce L Wilkoff
Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology.
The American journal of cardiology 2011;108(11):1576-80.
2011: Matthias Dupont; Wilfried Mullens; W H Wilson Tang
Impact of systemic venous congestion in heart failure.
Current heart failure reports 2011;8(4):233-41.
2011: Wilfried Mullens; W H Wilson Tang
The early intertwining of the heart and the kidney through an impaired natriuretic response to acute volume expansion.
Journal of the American College of Cardiology 2011;58(20):2104-5.
2011: W H Wilson Tang; William J Wickemeyer; John A Andriulli; Peter A Brady; Robin E Germany; Douglas A Hettrick; Bobbi L Hoppe; Shantanu Sarkar; Roy S Small
Uncovering interim clinical events at the time of clinical encounter by reviewing intrathoracic impedance threshold crossings.
Journal of cardiac failure 2011;17(11):893-8.
2011: John Rickard; Randall C Starling; W H Wilson Tang; Bruce L Wilkoff; Danielle M Brennan; Eileen Hsich; Bruce D Lindsay; David O Martin; Richard A Grimm
The impact of left ventricular size on response to cardiac resynchronization therapy.
American heart journal 2011;162(4):646-53.
2011: Michael A Samara; W H Wilson Tang
Device monitoring strategies in acute heart failure syndromes.
Heart failure reviews 2011;16(5):491-502.
2011: Sabe De; Leah Nye; James D Thomas; Heng Wang; Baozhong Xin; Allen G Borowski; W H Wilson Tang
Subclinical echocardiographic abnormalities in phenotype-negative carriers of myosin-binding protein C3 gene mutation for hypertrophic cardiomyopathy.
American heart journal 2011;162(2):262-267.e3.
2011: Matthias Dupont; Kevin Shrestha; W H Wilson Tang
Revisiting the cardio-renal hypothesis: the pivotal role of the kidney in congestive heart failure.
European journal of heart failure 2011;13(8):820-2.
2011: Vijaiganesh Nagarajan; W H Wilson Tang
Biomarkers in advanced heart failure: diagnostic and therapeutic insights.
Congestive heart failure (Greenwich, Conn.) 2011;17(4):169-74.
2011: Shantanu Sarkar; Roy Small; Cheuk-Man Yu; William T Abraham; Yanina Grinberg; Douglas A Hettrick; Jodi Koehler; Tyson Rogers; W H Wilson Tang
Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices.
Journal of cardiac failure 2011;17(7):569-76.
2011: Kevin Shrestha; Allen Borowski; Richard W Troughton; James D Thomas; Allan L Klein; W H Wilson Tang
Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failure.
Journal of cardiac failure 2011;17(6):472-8.
2011: Jaana Hartiala; Dalin Li; David V Conti; Susanna Vikman; Yesha Patel; W H Wilson Tang; Marie-Louise Brennan; John William Newman; Charles B Stephensen; Patrice Armstrong; Stanley L Hazen; Hooman Allayee
Genetic contribution of the leukotriene pathway to coronary artery disease.
Human genetics 2011;129(6):617-27.
2011: W H Wilson Tang; Kevin Shrestha; Richard W Troughton; Allen G Borowski; Allan L Klein
Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure.
Congestive heart failure (Greenwich, Conn.) 2011;17(3):105-9.
2011: Carmel M Halley; Jason M Lappé; Anne C Cotleur; Kevin Shrestha; Allen G Borowski; Clara Pelfrey; Richard Ransohoff; W H Wilson Tang
Antiinflammatory autoimmune cellular responses to cardiac troponin I in idiopathic dilated cardiomyopathy.
Journal of cardiac failure 2011;17(5):359-65.
2011: Zeneng Wang; Elizabeth Klipfell; Brian J Bennett; Robert Koeth; Bruce Levison; Brandon Dugar; Ariel E Feldstein; Earl B Britt; Xiaoming Fu; Yoon-Mi Chung; Yuping Wu; Phil Schauer; Jonathan D Smith; Hooman Allayee; W H Wilson Tang; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Nature 2011;472(7341):57-63.
2011: Samar Farha; Kewal Asosingh; Weiling Xu; Jacqueline Sharp; Deepa George; Suzy Comhair; Margaret Park; W H Wilson Tang; James E Loyd; Karl Theil; Raymond Tubbs; Eric Hsi; Alan Lichtin; Serpil C Erzurum
Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities.
Blood 2011;117(13):3485-93.
2011: Miram Jacob; W H Wilson Tang
Aldosterone-receptor antagonists in heart failure: insights after EMPHASIS-HF.
Current heart failure reports 2011;8(1):7-13.
2011: Bonnie Ky; Benjamin French; Kristin McCloskey; J Eduardo Rame; Erin McIntosh; Puja Shahi; Daniel L Dries; W H Wilson Tang; Alan H B Wu; James C Fang; Rebecca Boxer; Nancy K Sweitzer; Wayne C Levy; Lee R Goldberg; Mariell Jessup; Thomas P Cappola
High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure.
Circulation. Heart failure 2011;4(2):180-7.
2011: Andres Schuster; W H Wilson Tang
Ivabradine in heart failure: to SHIFT or not to SHIFT.
Current heart failure reports 2011;8(1):1-3.
2011: W H Wilson Tang; Michael A Samara
Polyunsaturated fatty acids in heart failure: should we give more and give earlier?
Journal of the American College of Cardiology 2011;57(7):880-3.
2011: W H Wilson Tang; Kevin Shrestha; Wilfried Mullens; Allen Borowski; Maureen G Martin; Richard W Troughton; Allan L Klein
Impact of left ventricular remodeling on diagnostic and prognostic value of tissue Doppler indices in chronic systolic heart failure.
Journal of cardiac failure 2011;17(2):128-34.
2011: W H Wilson Tang; Gary S Francis
Cardiac resynchronization therapy in patients with class I-II heart failure and a wide QRS: a cautionary note.
Circulation 2011;123(2):203-8.
2011: W H Wilson Tang; Yuping Wu; Shirley Mann; Michael Pepoy; Kevin Shrestha; Allen Borowski; Stanley L Hazen
Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure.
Circulation. Heart failure 2011;4(1):59-64.
2011: W H Wilson Tang; Yuping Wu; Stephen J Nicholls; Stanley L Hazen
Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.
Clinical chemistry 2011;57(1):33-9.
2010: Kevin Shrestha; W H Wilson Tang
Cardiorenal syndrome: diagnosis, treatment, and clinical outcomes.
Current heart failure reports 2010;7(4):167-74.
2010: Robert W Davies; Sonny Dandona; Alexandre Stewart; Li Chen; Stephan G Ellis; W H Wilson Tang; Stanley L Hazen; Robert Roberts; Ruth McPherson; George A Wells
Improved prediction of cardiovascular disease based on a panel of single nucleotide polymorphisms identified through genome-wide association studies.
Circulation. Cardiovascular genetics 2010;3(5):468-74.
2010: Stephen J Nicholls; W H Wilson Tang; Heather Scoffone; Danielle M Brennan; Jaana Hartiala; Hooman Allayee; Stanley L Hazen
Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy.
Journal of lipid research 2010;51(10):3055-61.
2010: Thomas Force; Robert O Bonow; Steven R Houser; R John Solaro; Ray E Hershberger; Bishow Adhikari; Mark E Anderson; Robin Boineau; Barry J Byrne; Thomas P Cappola; Raghu Kalluri; Martin M LeWinter; Martin S Maron; Jeffery D Molkentin; Steve R Ommen; Michael Regnier; W H Wilson Tang; Rong Tian; Marvin A Konstam; Barry J Maron; Christine E Seidman
Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.
Circulation 2010;122(11):1130-3.
2010: W H Wilson Tang; Kevin Shrestha; Maureen G Martin; Allen Borowski; Susan E Jasper; Timothy G Yandle; A Mark Richards; Allan L Klein; Richard W Troughton
Clinical significance of endogenous vasoactive neurohormones in chronic systolic heart failure.
Journal of cardiac failure 2010;16(8):635-40.
2010: Kevin Shrestha; Richard W Troughton; Allen Borowski; Timothy G Yandle; A Mark Richards; Allan L Klein; W H Wilson Tang
Plasma corin levels provide minimal prognostic utility incremental to natriuretic peptides in chronic systolic heart failure.
Journal of cardiac failure 2010;16(8):621-7.
2010: Marie-Luise Brennan; Anupama Reddy; W H Wilson Tang; Yuping Wu; Danielle M Brennan; Amy Hsu; Shirley A Mann; Peter L Hammer; Stanley L Hazen
Comprehensive peroxidase-based hematologic profiling for the prediction of 1-year myocardial infarction and death.
Circulation 2010;122(1):70-9.
2010: W H Wilson Tang; P S Daniel Yeo
Epidemiology of anemia in heart failure.
Heart failure clinics 2010;6(3):271-8.
2010: JoAnn Lindenfeld; Nancy M Albert; John Boehmer; Sean P Collins; Justin A Ezekowitz; Michael M Givertz; Stuart D Katz; Marc Klapholz; Debra K Moser; Joseph G Rogers; Randall C Starling; William G Stevenson; W H Wilson Tang; John R Teerlink; Mary N Walsh
HFSA 2010 Comprehensive Heart Failure Practice Guideline.
Journal of cardiac failure 2010;16(6):e1-194.
2010: W H Wilson Tang
Contemporary challenges in translating biomarker evidence into clinical practice.
Journal of the American College of Cardiology 2010;55(19):2077-9.
2010: Michael L Maitland; George L Bakris; Henry R Black; Helen X Chen; Jean-Bernard Durand; William J Elliott; S Percy Ivy; Carl V Leier; Joann Lindenfeld; Glenn Liu; Scot C Remick; Richard M Steingart; W H Wilson Tang
Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors.
Journal of the National Cancer Institute 2010;102(9):596-604.
2010: W H Wilson Tang; Gary S Francis
Statin treatment for patients with heart failure.
Nature reviews. Cardiology 2010;7(5):249-55.
2010: David Verhaert; Wilfried Mullens; Allen Borowski; Zoran B Popović; Ronan J Curtin; James David Thomas; W H Wilson Tang
Right ventricular response to intensive medical therapy in advanced decompensated heart failure.
Circulation. Heart failure 2010;3(3):340-6.
2010: W H Wilson Tang; Yuping Wu; Stephen J Nicholls; Danielle M Brennan; Michael Pepoy; Shirley Mann; Alan Pratt; Frederick Van Lente; Stanley L Hazen
Subclinical myocardial necrosis and cardiovascular risk in stable patients undergoing elective cardiac evaluation.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(3):634-40.
2010: W H Wilson Tang; Gary S Francis
The year in heart failure.
Journal of the American College of Cardiology 2010;55(7):688-96.
2010: W H Wilson Tang; Wilfried Mullens
Cardiorenal syndrome in decompensated heart failure.
Heart (British Cardiac Society) 2010;96(4):255-60.
2010: Sarinya Puwanant; Margaret Park; Zoran B Popović; W H Wilson Tang; Samar Farha; Deepa George; Jacqueline Sharp; Jirapa Puntawangkoon; James E Loyd; Serpil C Erzurum; James David Thomas
Ventricular geometry, strain, and rotational mechanics in pulmonary hypertension.
Circulation 2010;121(2):259-66.
2010: Arash Aghel; Kevin Shrestha; Wilfried Mullens; Allen Borowski; W H Wilson Tang
Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure.
Journal of cardiac failure 2010;16(1):49-54.
2010: Sonny Dandona; Li Chen; Meng Fan; Md Afaque Alam; Olivia Assogba; Melanie Belanger; Kathryn Williams; George A Wells; W H Wilson Tang; Stephen G Ellis; Stanley L Hazen; Ruth McPherson; Robert Roberts; Alexandre Stewart
The transcription factor GATA-2 does not associate with angiographic coronary artery disease in the Ottawa Heart Genomics and Cleveland Clinic GeneBank Studies.
Human genetics 2010;127(1):101-5.
2009: Bethany A Austin; W H Wilson Tang; E Rene Rodriguez; Carmela Tan; Scott D Flamm; David O Taylor; Randall C Starling; Milind Y Desai
Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis.
JACC. Cardiovascular imaging 2009;2(12):1369-77.
2009: Sarinya Puwanant; Brandon C Varr; Kevin Shrestha; Sarah K Hussain; W H Wilson Tang; Ruvin S Gabriel; Oussama Wazni; Mandeep Bhargava; Walid I Saliba; James David Thomas; Bruce D Lindsay; Allan L Klein
Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation.
Journal of the American College of Cardiology 2009;54(22):2032-9.
2009: Gary S Francis; W H Wilson Tang
Early cardiac resynchronization therapy and reverse remodeling in patients with mild heart failure: is it time?
Circulation 2009;120(19):1845-6.
2009: W H Wilson Tang
Enhancing the prognostic value of cardiac imaging with multimodal risk assessment.
JACC. Cardiovascular imaging 2009;2(9):1100-2.
2009: Slava Epelman; Kevin Shrestha; Richard W Troughton; Gary S Francis; Subha Sen; Allan L Klein; W H Wilson Tang
Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes.
Journal of cardiac failure 2009;15(7):565-71.
2009: Zeneng Wang; W H Wilson Tang; Leslie Cho; Danielle M Brennan; Stanley L Hazen
Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(9):1383-91.
2009: Roy S Small; William Wickemeyer; Robin Germany; Bobbi Hoppe; John Andrulli; Peter A Brady; Melody Labeau; Jodi Koehler; Shantanu Sarkar; Douglas A Hettrick; W H Wilson Tang
Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
Journal of cardiac failure 2009;15(6):475-81.
2009: W H Wilson Tang
Impedance monitoring in heart failure: are we really measuring hemodynamics?
American heart journal 2009;158(2):152-3.
2009: W H Wilson Tang
Natriuretic Peptide measurements in managing heart failure: in theory and in practice.
Circulation. Heart failure 2009;2(4):380-1.
2009: W H Wilson Tang; Zeneng Wang; Leslie Cho; Danielle M Brennan; Stanley L Hazen
Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk.
Journal of the American College of Cardiology 2009;53(22):2061-7.
2009: John A Sallach; W H Wilson Tang; Allen G Borowski; Wilson Tong; Tama Porter; Maureen G Martin; Susan E Jasper; Kevin Shrestha; Richard W Troughton; Allan L Klein
Right atrial volume index in chronic systolic heart failure and prognosis.
JACC. Cardiovascular imaging 2009;2(5):527-34.
2009: W H Wilson Tang; Ronit Katz; Marie-Luise Brennan; Ronnier J Aviles; Russell P Tracy; Bruce M Psaty; Stanley L Hazen
Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure.
The American journal of cardiology 2009;103(9):1269-74.
2009: Adisai Buakhamsri; Zoran B Popovic; Jingna Lin; Pascal Lim; Neil L Greenberg; Allen Borowski; W H Wilson Tang; Allan L Klein; Harry M Lever; Milind Y Desai; James David Thomas
Impact of left ventricular volume/mass ratio on diastolic function.
European heart journal 2009;30(10):1213-21.
2009: Wilfried Mullens; Zuheir Abrahams; Gary S Francis; George Sokos; Randall C Starling; James B Young; David O Taylor; W H Wilson Tang
Usefulness of Isosorbide Dinitrate and Hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure.
The American journal of cardiology 2009;103(8):1113-9.
2009: Wilfried Mullens; Richard A Grimm; Tanya Verga; Thomas Dresing; Randall C Starling; Bruce L Wilkoff; W H Wilson Tang
Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program.
Journal of the American College of Cardiology 2009;53(9):765-73.
2009: W H Wilson Tang; Wilson Tong
Measuring impedance in congestive heart failure: current options and clinical applications.
American heart journal 2009;157(3):402-11.
2009: Wilfried Mullens; Tanya Verga; Richard A Grimm; Randall C Starling; Bruce L Wilkoff; W H Wilson Tang
Persistent hemodynamic benefits of cardiac resynchronization therapy with disease progression in advanced heart failure.
Journal of the American College of Cardiology 2009;53(7):600-7.
2009: Wilfried Mullens; Zuheir Abrahams; Gary S Francis; George Sokos; David O Taylor; Randall C Starling; James B Young; W H Wilson Tang
Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.
Journal of the American College of Cardiology 2009;53(7):589-96.
2009: Wilfried Mullens; Allen Borowski; Ronan J Curtin; James David Thomas; W H Wilson Tang
Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure.
Circulation 2009;119(1):62-70.
2009: W H Wilson Tang
The metabolic approach in patients with heart failure: effects on left ventricle remodeling.
Current pharmaceutical design 2009;15(8):850-6.
2008: W H Wilson Tang; Wilfried Mullens; Allen Borowski; Wilson Tong; Kevin Shrestha; Richard W Troughton; Maureen G Martin; Kathleen Kassimatis; Debbie Agler; Sue Jasper; Richard A Grimm; Randall C Starling; Allan L Klein
Relation of mechanical dyssynchrony with underlying cardiac structure and performance in chronic systolic heart failure: implications on clinical response to cardiac resynchronization.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(12):1370-4.
2008: W H Wilson Tang; Gary S Francis
The year in heart failure.
Journal of the American College of Cardiology 2008;52(20):1671-8.
2008: Ashish Aneja; W H Wilson Tang; Sameer Bansilal; Mario J. Garcia; Michael E Farkouh
Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options.
The American journal of medicine 2008;121(9):748-57.
2008: Slava Epelman; W H Wilson Tang; Stephen Y Chen; Frederick Van Lente; Gary S Francis; Subha Sen
Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system.
Journal of the American College of Cardiology 2008;52(9):750-4.
2008: Wilfried Mullens; Allen Borowski; Ronan Curtin; Richard A Grimm; James David Thomas; W H Wilson Tang
Mechanical dyssynchrony in advanced decompensated heart failure: relation to hemodynamic responses to intensive medical therapy.
Heart rhythm : the official journal of the Heart Rhythm Society 2008;5(8):1105-10.
2008: Jason M Lappé; Clara M Pelfrey; W H Wilson Tang
Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.
Journal of cardiac failure 2008;14(6):521-30.
2008: Wilfried Mullens; Zuheir Abrahams; Gary S Francis; David O Taylor; Randall C Starling; W H Wilson Tang
Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure.
Journal of cardiac failure 2008;14(6):508-14.
2008: Wilfried Mullens; Zuheir Abrahams; Gary S Francis; Hadi N Skouri; Randall C Starling; James B Young; David O Taylor; W H Wilson Tang
Sodium nitroprusside for advanced low-output heart failure.
Journal of the American College of Cardiology 2008;52(3):200-7.
2008: W H Wilson Tang
The ongoing search for a stratified medicine approach in heart failure.
Journal of the American College of Cardiology 2008;51(24):2310-2.
2008: Arash Aghel; W H Wilson Tang
Tolvaptan: the evidence for its therapeutic value in acute heart failure syndrome.
Core evidence 2008;3(1):31-43.
2008: W H Wilson Tang; Frederick Van Lente; Kevin Shrestha; Richard W Troughton; Gary S Francis; Wilson Tong; Maureen G Martin; Allen Borowski; Susan E Jasper; Randall C Starling; Allan L Klein
Impact of myocardial function on cystatin C measurements in chronic systolic heart failure.
Journal of cardiac failure 2008;14(5):394-9.
2008: Wilfried Mullens; Zuheir Abrahams; Hadi N Skouri; David O Taylor; Randall C Starling; Gary S Francis; James B Young; W H Wilson Tang
Prognostic evaluation of ambulatory patients with advanced heart failure.
The American journal of cardiology 2008;101(9):1297-302.
2008: Ye Olivia Xu-Cai; Daniel J Brotman; Christopher O Phillips; Franklin A Michota; W H Wilson Tang; Christopher M Whinney; Ashok Panneerselvam; Eric D Hixson; Mario J. Garcia; Gary S Francis; Amir K Jaffer
Outcomes of patients with stable heart failure undergoing elective noncardiac surgery.
Mayo Clinic proceedings. Mayo Clinic 2008;83(3):280-8.
2007: W H Wilson Tang; Gary S Francis
The year in heart failure.
Journal of the American College of Cardiology 2007;50(24):2344-51.
2007: Wilfried Mullens; W H Wilson Tang; Richard A Grimm
Using echocardiography in cardiac resynchronization therapy.
American heart journal 2007;154(6):1011-20.
2007: W H Wilson Tang
Pharmacologic therapy for acute heart failure.
Cardiology clinics 2007;25(4):539-51; vi.
2007: W H Wilson Tang; Gary S Francis
Exploring new drugs for heart failure: the case of urocortin.
European heart journal 2007;28(21):2561-2.
2007: Fred S Apple; Alan H B Wu; Allan S Jaffe; Mauro Panteghini; Robert H Christenson; Christopher P Cannon; Gary Francis; Robert L Jesse; David A Morrow; L Kristin Newby; Alan Storrow; W H Wilson Tang; Franca Pagani; Jillian Tate; Jordi Ordonez-Llanos; Johannes Mair
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.
Circulation 2007;116(5):e95-8.
2007: W H Wilson Tang; Gary S Francis; David A Morrow; L Kristin Newby; Christopher P Cannon; Robert L Jesse; Alan Storrow; Robert H Christenson; Fred S Apple; Jan Ravkilde; Alan H B Wu
National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.
Circulation 2007;116(5):e99-109.
2007: Srinivasa R Kalidindi; W H Wilson Tang; Gary S Francis
Drug insight: aldosterone-receptor antagonists in heart failure--the journey continues.
Nature clinical practice. Cardiovascular medicine 2007;4(7):368-78.
2007: W H Wilson Tang; Anjli Maroo
PPARgamma agonists: safety issues in heart failure.
Diabetes, obesity & metabolism 2007;9(4):447-54.
2007: W H Wilson Tang; Wilson Tong; Richard W Troughton; Maureen G Martin; Kevin Shrestha; Allen Borowski; Susan E Jasper; Stanley L Hazen; Allan L Klein
Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure.
Journal of the American College of Cardiology 2007;49(24):2364-70.
2007: W H Wilson Tang
Collaboration among general cardiologists, heart failure specialists, and electrophysiologists: what are the barriers?
The American journal of cardiology 2007;99(10A):41G-4G.
2007: W H Wilson Tang
Glycemic control and treatment patterns in patients with heart failure.
Current cardiology reports 2007;9(3):242-7.
2007: Stephen Y Chen; W H Wilson Tang
Emerging drugs for acute and chronic heart failure: current and future developments.
Expert opinion on emerging drugs 2007;12(1):75-95.
2007: W H Wilson Tang; Gary S Francis
Cardiac resynchronization therapy in New York Heart Association class IV heart failure: it is all about selection.
Circulation 2007;115(2):161-2.
2007: W H Wilson Tang
A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus.
Vascular health and risk management 2007;3(5):639-45.
2007: W H Wilson Tang
Anemia in heart failure:current evidence and challenges.
Reviews in cardiovascular medicine 2007;8(2):78-86.
2007: Girish Mood; W H Wilson Tang
Preventing venous thromboembolism in cardiology and cardiac surgery.
Surgical technology international 2007;16():179-83.
2007: W H Wilson Tang
B-type natriuretic peptide: a critical review.
Congestive heart failure (Greenwich, Conn.) 2007;13(1):48-52.
2007: W H Wilson Tang; Steven R Steinhubl; Frederick Van Lente; Danielle Brennan; Ellen McErlean; Anjli Maroo; Gary S Francis; Eric J Topol
Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.
American heart journal 2007;153(1):36-41.
2006: W H Wilson Tang; Gary S Francis
The year in heart failure.
Journal of the American College of Cardiology 2006;48(12):2575-83.
2006: Gary S Francis; W H Wilson Tang
Histamine, mast cells, and heart failure: is there a connection?
Journal of the American College of Cardiology 2006;48(7):1385-6.
2006: W H Wilson Tang; Marie-Luise Brennan; Kiran Philip; Wilson Tong; Shirley Mann; Frederick Van Lente; Stanley L Hazen
Plasma myeloperoxidase levels in patients with chronic heart failure.
The American journal of cardiology 2006;98(6):796-9.
2006: W H Wilson Tang
Metabolic approach in heart failure: rethinking how we translate from theory to clinical practice.
Journal of the American College of Cardiology 2006;48(5):999-1000.
2006: Arti Choure; W H Wilson Tang; Roger Mills
Natriuretic peptides in valvular heart diseases.
Heart failure clinics 2006;2(3):345-52.
2006: W H Wilson Tang
Natriuretic peptides in screening for cardiac dysfunction.
Heart failure clinics 2006;2(3):323-32.
2006: W H Wilson Tang
Biomarker screening for cardiac dysfunction: the more the merrier?
American heart journal 2006;152(1):1-3.
2006: W H Wilson Tang
New approaches to detect and manage edema and renal insufficiency in heart failure.
Cleveland Clinic journal of medicine 2006;73 Suppl 2():S14-9; discussion S30-3.
2006: Walter Coats; Anjli Maroo; Tjuan L Overly; W H Wilson Tang
Changing conduction abnormalities in a dialysis patient with fever.
Cardiology in review 2006;14(3):158-60.
2006: W H Wilson Tang
Do thiazolidinediones cause heart failure? A critical review.
Cleveland Clinic journal of medicine 2006;73(4):390-7.
2006: W H Wilson Tang
Case studies in advanced monitoring: OptiVol.
Reviews in cardiovascular medicine 2006;7 Suppl 1():S62-6.
2006: Robert H Christenson; W H Wilson Tang
Institute for Quality in Laboratory Medicine series--controversies in laboratory medicine: insights into B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide measurements.
MedGenMed : Medscape general medicine 2006;8(2):62.
2006: W H Wilson Tang
Glycemic control and treatment patterns in patients with heart failure.
Heart failure monitor 2006;5(1):10-4.
2005: W H Wilson Tang; Gary S Francis
The year in heart failure.
Journal of the American College of Cardiology 2005;46(11):2125-33.
2005: W H Wilson Tang; Anoop C Parameswaran; Anjli Maroo; Gary S Francis
Aldosterone receptor antagonists in the medical management of chronic heart failure.
Mayo Clinic proceedings. Mayo Clinic 2005;80(12):1623-30.
2005: W H Wilson Tang; Gary S Francis
The difficult task of evaluating how to monitor patients with heart failure.
Journal of cardiac failure 2005;11(6):422-4.
2005: W H Wilson Tang; Sanjeev Bhavnani; Gary S Francis
Vasopressin receptor antagonists in the management of acute heart failure.
Expert opinion on investigational drugs 2005;14(5):593-600.
2005: Anoop C Parameswaran; W H Wilson Tang; Gary S Francis; Ritesh Gupta; James B Young
Why do patients fail to receive beta-blockers for chronic heart failure over time? A "real-world" single-center, 2-year follow-up experience of beta-blocker therapy in patients with chronic heart failure.
American heart journal 2005;149(5):921-6.
2005: Gary S Francis; W H Wilson Tang
Should we consider aldosterone as the primary screening target for preventing cardiovascular events?
Journal of the American College of Cardiology 2005;45(8):1249-50.
2005: W H Wilson Tang; Gary S Francis
Neurohormonal upregulation in heart failure.
Heart failure clinics 2005;1(1):1-9.
2005: W H Wilson Tang; Kiran Philip; Stanley L Hazen; Cindy E Stevenson; Michael Pepoy; Sarah Neale; Gary S Francis; Frederick Van Lente; Andrew Smith; Alan H B Wu
Comparative sensitivities between different plasma B-type natriuretic peptide assays in patients with minimally symptomatic heart failure.
Clinical cornerstone 2005;7 Suppl 1():S18-24.
2004: W H Wilson Tang; A Michael Lincoff
Diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa blockade: the triad revisited.
Circulation 2004;110(24):3618-20.
2004: Gary S Francis; W H Wilson Tang
Cardiac troponins in renal insufficiency and other non-ischemic cardiac conditions.
Progress in cardiovascular diseases 2004;47(3):196-206.
2004: W H Wilson Tang; Randall H Vagelos; Yin-Gail Yee; Michael B Fowler
Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure.
American heart journal 2004;148(5):889-94.
2004: Oussama Wazni; David O Martin; Nassir F Marrouche; Ahmed Abdel Latif; Khaled M Ziada; Mustaphasahim Shaaraoui; Soufian Almahameed; Robert A Schweikert; Walid I Saliba; A Marc Gillinov; W H Wilson Tang; Roger Mills; Gary S Francis; James B Young; Andrea Natale
Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery.
Circulation 2004;110(2):124-7.
2004: Ronald M Witteles; W H Wilson Tang; Aamer H Jamali; James W Chu; Gerald M Reaven; Michael B Fowler
Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link.
Journal of the American College of Cardiology 2004;44(1):78-81.
2004: W H Wilson Tang; Anjli Maroo; James B Young
Ischemic heart disease and congestive heart failure in diabetic patients.
The Medical clinics of North America 2004;88(4):1037-61, xi-xii.
2004: Patrick J Nash; Robin K Avery; W H Wilson Tang; Randall C Starling; Alan J Taege; Mohamad H Yamani
Encephalitis owing to human herpesvirus-6 after cardiac transplant.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(7):1200-3.
2004: W H Wilson Tang; Gary S Francis
Evolving concepts in left ventricular systolic and diastolic remodeling: implications for therapy.
Current cardiology reports 2004;6(3):200-4.
2004: Gary S Francis; W H Wilson Tang
Vasopressin receptor antagonists: will the "vaptans" fulfill their promise?
JAMA : the journal of the American Medical Association 2004;291(16):2017-8.
2004: Hitinder S Gurm; A Michael Lincoff; David S Lee; W H Wilson Tang; Gang Jia; Joan E Booth; Robert M Califf; Erik Ohman; Frans Van de Werf; Paul W Armstrong; Victor Guetta; Robert Wilcox; Eric J Topol
Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.
Journal of the American College of Cardiology 2004;43(4):542-8.
2004: Ritesh Gupta; W H Wilson Tang; James B Young
Patterns of beta-blocker utilization in patients with chronic heart failure: experience from a specialized outpatient heart failure clinic.
American heart journal 2004;147(1):79-83.
2003: W H Wilson Tang; John P Girod; Michael J Lee; Randall C Starling; James B Young; Frederick Van Lente; Gary S Francis
Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure.
Circulation 2003;108(24):2964-6.
2003: W H Wilson Tang; Michael Militello; Gary S Francis
In heart failure, all beta-blockers are not necessarily equal.
Cleveland Clinic journal of medicine 2003;70(12):1081-7.
2003: W H Wilson Tang; Gary S Francis
Novel pharmacological treatments for heart failure.
Expert opinion on investigational drugs 2003;12(11):1791-801.
2003: John P Girod; Adrian W Messerli; Frank Zidar; W H Wilson Tang; Sorin J Brener
Images in cardiovascular medicine. Tako-tsubo--like transient left ventricular dysfunction.
Circulation 2003;107(18):e120-1.
2003: W H Wilson Tang; Gary S Francis; Byron J Hoogwerf; James B Young
Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure.
Journal of the American College of Cardiology 2003;41(8):1394-8.
2003: Gary S Francis; W H Wilson Tang
Beta-blockers and reverse remodeling: what are the implications?
American heart journal 2003;145(2):200-2.
2003: W H Wilson Tang; Gary S Francis
Spironolactone in chronic heart failure:all's well that ends well.
Journal of the American College of Cardiology 2003;41(2):215-6.
2003: W H Wilson Tang; Gary S Francis
Trends and treatment of heart failure developing after acute myocardial infarction.
The American heart hospital journal 2003;1(3):216-8.
2003: Gary S Francis; W H Wilson Tang
Pathophysiology of congestive heart failure.
Reviews in cardiovascular medicine 2003;4 Suppl 2():S14-20.
2002: Benjamin J Freda; W H Wilson Tang; Frederick Van Lente; W Frank Peacock; Gary S Francis
Cardiac troponins in renal insufficiency: review and clinical implications.
Journal of the American College of Cardiology 2002;40(12):2065-71.
2002: Debabrata Mukherjee; Hitinder S Gurm; W H Wilson Tang; Marco Roffi; Kathy Wolski; David J Moliterno; Victor Guetta; Diego Ardissinio; Christopher Bode; Gabriel Steg; A Michael Lincoff; Eric J Topol
Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab.
The American journal of cardiology 2002;90(11):1198-203.
2002: W H Wilson Tang; Randall H Vagelos; Yin Gail Yee; Claude R Benedict; Kathy Willson; Charles L Liss; Michael B Fowler
Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure.
Journal of the American College of Cardiology 2002;39(1):70-8.
2001: W H Wilson Tang; G S Francis
Polypharmacy of heart failure. Creating a rational pharmacotherapeutic protocol.
Cardiology clinics 2001;19(4):583-96, viii.
2001: Shuichiro Kaji; Phillip C Yang; Adam B Kerr; W H Wilson Tang; Craig H Meyer; Albert Macovski; John Pauly; Dwight G Nishimura; Bob S Hu
Rapid evaluation of left ventricular volume and mass without breath-holding using real-time interactive cardiac magnetic resonance imaging system.
Journal of the American College of Cardiology 2001;38(2):527-33.